NEW YORK, NY / ACCESSWIRE / May 12, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
DouYu International Holdings Limited (NASDAQ:DOYU)
Class Period: stock in the initial public offering pursuant and/or traceable to the documents used by defendants to conduct the initial public offering.
Lead Plaintiff Deadline: May 26, 2020
According to the complaint, DouYu International Holdings Limited allegedly made materially false and/or misleading statements and/or failed to disclose that: as of the initial public offering: (i) DouYu's risks related to its top streamers had materialized, including that: (a) a top streamer was actively misrepresenting herself on DouYu's platform;and (b) costs associated with retaining top streamers was swelling; (ii) DouYu did not ensure that all of its products were fully compliant with current regulatory requirements before those products became available online; and (iii) key interactive features of DouYu's "lucky draw"were non-compliant with current regulatory requirements.
Learn about your recoverable losses in DOYU: http://www.kleinstocklaw.com/pslra-1/douyu-international-holdings-limited-loss-submission-form?id=6457&from=1
AnaptysBio, Inc. (NASDAQ:ANAB)
Class Period: October 10, 2017 to November 7, 2019
Lead Plaintiff Deadline: May 26, 2020
The ANAB lawsuit alleges that AnaptysBio, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) AnaptysBio failed to disseminate important data from the Company's Phase 2a trial in atopic dermatitis, including the timing and extent of patients' use of topical corticosteroids as a rescue therapy during the study and whether any of the patients that utilized rescue therapy were classified as responders at a given time;and (ii) the Company's statements omitted key information from the Company's Phase 2a trial in peanut allergy, including patients' average cumulative peanut dose tolerated at day 14 after the administration of etokimab or placebo as well as whether the Company's decision to exclude 20% of the patients enrolled in the study from the interim analysis due to their mild symptoms was retrospective; and (ii) as a result of the foregoing, Defendants' positive statements about the efficacy and prospects of AnaptysBio's lead drug asset in the treatment of atopic dermatitis and peanut allergy were materially false and/or misleading and/or lacked a reasonable basis.
Learn about your recoverable losses in ANAB: http://www.kleinstocklaw.com/pslra-1/anaptysbio-inc-loss-submission-form?id=6457&from=1
Liberty Oilfield Services, Inc. (NYSE:LBRT)
Class Period: securities pursuant and/or traceable to the documents issued in connection with the Company's January 2018 initial public offering.
Lead Plaintiff Deadline: June 2, 2020
The LBRT lawsuit alleges Liberty Oilfield Services, Inc. made materially false and/or misleading statements and/or failed to disclose during the class period that: (1) there was an oversupply in the hydraulic fracturing services market; (2) the Company's pricing power was weak; (3) Liberty's services were not increasing and its competition was not decreasing; and (4) as a result, Defendants' statements about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
Learn about your recoverable losses in LBRT: http://www.kleinstocklaw.com/pslra-1/liberty-oilfield-services-inc-loss-submission-form?id=6457&from=1
Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
[email protected]
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com
SOURCE: The Klein Law Firm